Progressive Relapsed Hodgkin’s Lymphoma


Panobinostat Promising in Relapsed/Refractory Hodgkin’s Lymphoma (11-9-2010)

An ongoing study of the experimental drug panobinostat (LBH-589) reports promising activity in heavily pretreated patients with relapsed and refractory Hodgkin’s lymphoma (HL). These findings were presented at the 2010 annual meeting of the American... Continue Reading

Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma (09-24-2009)

Children and adolescents with relapsed Hodgkin’s lymphoma respond well to allogeneic stem cell transplantation, according to the results of a study published in Blood.[1] Although children and adolescents with Hodgkin’s lymphoma have an excellent... Continue Reading

Hodgkin’s Survivors at Increased Risk of Stroke (06-24-2009)

Hodgkin’s Survivors at Increased Risk of Stroke Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke. These results were published in the Journal of the National Cancer Institute. Hodgkin’s... Continue Reading

Autologous Stem Cell Transplantation Effective for Relapsed Hodgkin’s Lymphoma (03-8-2009)

Autologous Stem Cell Transplantation Effective for Relapsed Hodgkin’s Lymphoma Autologous stem cell transplantation is effective for patients with Hodgkin’s lymphoma that has progressed following prior therapies. These results were recently... Continue Reading

Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid Complications (02-5-2009)

According to an article published in the Annals of Oncology, survivors of Hodgkin’s lymphoma have a significantly increased rate of cardiac and thyroid complications than their siblings. In addition, survivors tend to have more fatigue than their siblings;... Continue Reading

« Previous Page